MCM
COLL icon

MAI Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

MAI Capital Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,235
Closed -$107K – 2599
2026
Q1 		$107K Buy
3,235
+35
+1% +$1.48K ﹤0.01% 1796
2025
Q4 		$148K Hold
3,200
– – ﹤0.01% 1435
2025
Q3 		$112K Sell
3,200
-63
-2% -$2.19K ﹤0.01% 1516
2025
Q2 		$96.5K Buy
3,263
+63
+2% +$1.8K ﹤0.01% 1505
2025
Q1 		$95.5K Hold
3,200
– – ﹤0.01% 1428
2024
Q4 		$91.7K Buy
+3,200
New +$106K ﹤0.01% 1480

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

MAI Capital Management's COLL Position: Q2 2026 in Review

MAI Capital Management sold out of Collegium Pharmaceutical (COLL) in Q2 2026, closing a stake of 3,235 shares — an estimated $107K sold.

MAI Capital Management first reported a position in COLL in Q4 2024 and held it in 6 quarters. The position peaked at $148K in Q4 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • MAI Capital Management reported no remaining Collegium Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • MAI Capital Management sold 3,235 Collegium Pharmaceutical shares in Q2 2026, an estimated $107K.
  • MAI Capital Management first reported a position in Collegium Pharmaceutical in Q4 2024 and held it in 6 quarters.
  • MAI Capital Management's Collegium Pharmaceutical position peaked at $148K in Q4 2025.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.